WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...
Analyst Jason Butler from JMP Securities reiterated a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report) and keeping the price target at $23.00. Jason Butler has given his Buy rating due ...
On the eighth day of demonstrations, the organization leading the encampment, "Hopkins Justice Collective," hosted a vigil with a group called "American Muslims for Palestine." ...